Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_3
4
29%
Ph not_applicable
3
21%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
4(57.1%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(10)
Other(4)

Detailed Status

Completed10
unknown4

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (57.1%)
N/A3 (42.9%)

Trials by Status

unknown429%
completed1071%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DRUG
Total Trials
14